Äڷγª19(COVID-19) ¹é½Å : ±âȸ Æò°¡¿Í ¿¹Ãø(-2026³â)
Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026
»óǰÄÚµå : 1017539
¸®¼­Ä¡»ç : GlobalData
¹ßÇàÀÏ : 2021³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 73 Pages
US $ 10,995 £Ü 14,042,000
PDF (Single User License) help
1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº Copy & Paste°¡ °¡´ÉÇÕ´Ï´Ù. ÀμâȽ¼ö¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿¡ ÁØÇÕ´Ï´Ù.
US $ 21,990 £Ü 28,085,000
PDF (Site License) help
µ¿ÀÏ »ç¾÷Àå ³» ¸ðµç ºÐµéÀÌ °øÀ¯ÇÏ¿© »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ¿ë Àοø¼ö¿¡ Á¦ÇÑÀº ¾ø½À´Ï´Ù. PDF ÆÄÀÏÀº Copy & Paste°¡ °¡´ÉÇÕ´Ï´Ù. PDF ³»ÀÇ ÄÁÅÙÃ÷ Àμâ´Â Á¦ÇÑÀÌ ¾øÀ¸³ª, Àüüº¸°í¼­¿¡ ´ëÇÑ Á¦º»Àº ¿øÄ¢ÀûÀ¸·Î 2ºÎ±îÁö¸¸ Çã¿ëµÇ¸ç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿¡ ÁØÇÕ´Ï´Ù.
US $ 32,985 £Ü 42,128,000
PDF (Global License) help
µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐµéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¼ö¿¡ Á¦ÇÑÀº ¾øÀ¸¸ç, ÇØ¿Ü »ç¾÷Àå ¹× 100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ. PDF ÆÄÀÏÀº Copy & Paste°¡ °¡´ÉÇÕ´Ï´Ù. PDF ³»ÀÇ ÄÁÅÙÃ÷ Àμâ´Â Á¦ÇÑÀÌ ¾øÀ¸³ª, Àüüº¸°í¼­¿¡ ´ëÇÑ Á¦º»Àº ¿øÄ¢ÀûÀ¸·Î 10ºÎ±îÁö¸¸ Çã¿ëµÇ¸ç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿¡ ÁØÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

COVID-19 ¹é½ÅÀÇ ÇâÈÄ »ç¿ë¿¡ ´ëÇØ ¼¼°¡ÁöÀÇ ´Ù¸¥ ÀáÀçÀû ½Ã³ª¸®¿À°¡ ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ù¹øÂ° ½Ã³ª¸®¿À¿¡¼­´Â COVID-19 ¹é½Å ¿¬Â÷ Á¢Á¾ÀÌ ÇÊ¿äÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. µÎ¹øÂ° ½Ã³ª¸®¿À¿¡¼­´Â 65¼¼ ÀÌ»ó °íÀ§Ç豺¿¡°Ô´Â ¸Å³â ¹é½Å Á¢Á¾À» »óÁ¤Çϰí, 65¼¼ ÀÌÇÏ¿¡°Ô´Â 2³â¿¡ Çѹø¾¿ ¹é½Å Á¢Á¾ÀÌ ÇÊ¿äÆÈ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ¼¼¹øÂ° ½Ã³ª¸®¿À¿¡¼­´Â 65¼¼ ÀÌ»ó °íÀ§Ç豺Àº 2³â¸¶´Ù COVID-19 ¹é½ÅÀ» Á¢Á¾Çϰí, 65¼¼ ÀÌÇÏ´Â 5³â¸¶´Ù ¹é½ÅÀ» Á¢Á¾Çصµ ±¦Âú´Ù°í ÇÏ´Â °ÍÀÔ´Ï´Ù.

Äڷγª19(COVID-19) ¹é½Å ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, Áúȯ °³¿ä, ÃæÁ·µÇÁö ¾ÊÀº ¿å±¸¿Í ±âȸ, ¿¬±¸°³¹ß µ¿Çâ, ÆÄÀÌÇÁ¶óÀÎ °³¿ä¿Í Á¦Ç° °³¿ä µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Áúº´ °³¿ä

Á¦3Àå ¿ªÇÐ

Á¦4Àå ÇöÀçÀÇ ¹é½Å Á¢Á¾ ¿É¼Ç

Á¦5Àå ÃæÁ·µÇÁö ¾ÊÀº ¿å±¸¿Í ±âȸ

Á¦6Àå ÆÄÀÌÇÁ¶óÀÎ Æò°¡

Á¦7Àå ¿¬±¸°³¹ß Àü·«

Á¦8Àå ½ÃÀå Àü¸Á

Á¦9Àå ºÎ·Ï

Á¦10Àå ¹®ÀÇ

LSH 21.08.19
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026 gives a COVID-19 disease overview, epidemiology overview, current marketed vaccines, unmet needs, pipeline assessment, and market outlook.

GlobalData forecast three different potential scenarios for the future use of COVID-19 vaccines -

Scope

This report includes -

Reasons to Buy

Table of Contents

Table of Contents

1 Executive Summary

2 Disease Overview

3 Epidemiology

4 Current Vaccination Options

5 Unmet Needs and Opportunities

6 Pipeline Assessment

7 R&D Strategies

8 Market Outlook

9 Appendix

10 Contact Us

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â